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Abstract
Neuropathological subtypes of hippocampal sclerosis (HS) in temporal lobe epilepsy
(The 2013 International League Against Epilepsy classiﬁcation) are based on the
qualitative assessment of patterns of neuronal loss with NeuN. In practice, some cases appear
indeterminate between type 1 (CA1 and CA4 loss) and type 2 HS (CA1 loss) and we
predicted that MAP2 would enable a more stringent classiﬁcation. HS subtypes, as well
as the accompanying alteration of axonal networks, regenerative capacity and
neurodegeneration have been previously correlated with outcome and memory deﬁcits and
may provide prognostic clinical information. We selected 92 cases: 52 type 1 HS, 15 type 2
HS, 18 indeterminate-HS and 7 no-HS. Quantitative analysis was carried out on NeuN and
MAP2 stained sections and a labeling index (LI) calculated for six hippocampal subﬁelds.
We also evaluated hippocampal regenerative activity (MCM2, nestin, olig2, calbindin),
degeneration (AT8/phosphorylated tau) and mossy-ﬁber pathway re-organization (ZnT3).
Pathology measures were correlated with clinical epilepsy history, memory and naming test
scores and postoperative outcomes, at 1 year following surgery. MAP2 LI in indeterminate-
HS was statistically similar to type 2 HS but this clustering was not shown with NeuN.
Moderate verbal and visual memory deﬁcits were noted in all HS types, including 54% and
69% of type 2 HS. Memory deﬁcits correlated with several pathology factors including lower
NeuN or MAP2 LI in CA4, CA1, dentate gyrus (DG) and subiculum and poor preservation
of the mossy ﬁber pathway. Decline in memory at 1 year associated with AT8 labeling in the
subiculum and DG but not HS type. We conclude that MAP2 is a helpful addition in the
classiﬁcation of HS in some cases. Classiﬁcation of HS subtype, however, did not
signiﬁcantly correlate with outcome or pre- or postoperative memory dysfunction, which was
associated with multiple pathology factors including hippocampal axonal pathways,
regenerative capacity and degenerative changes.
INTRODUCTION
The 2013 International League Against Epilepsy (ILAE) classiﬁca-
tion of hippocampal sclerosis (HS) in temporal lobe epilepsy (TLE)
(8) was introduced to integrate previous terminology and provide a
robust semiquantitative scoring scheme that could be of potential
clinical and prognostic relevance to patients undergoing epilepsy sur-
gery. It has subsequently been implemented in recent reported series
of TLE patients (10, 12, 28, 33, 48). This classiﬁcation includes the
segregation of the common or typical pattern of HS (type 1, with neu-
ronal loss in CA4 and CA1) from type 2 HS (neuronal loss restricted
to CA1 subﬁeld) and type 3 HS (neuronal loss restricted to CA4 sub-
ﬁeld) based on NeuN stained sections. In practice, however, it can be
difﬁcult in some cases to distinguish type 1 from type 2 HS based on
determining CA4 neuronal loss with nuclear NeuN immunolabeling.
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Nevertheless, there is emerging data suggesting the ILAE classiﬁ-
cation system enables the identiﬁcation of HS/TLE phenotypes that
could account for clinical variability. HS subtypes may be predictive
of seizure-free outcomes following surgery (12, 28) and subtypes of
HS and patterns of subﬁeld neuronal loss have been associated with
speciﬁc memory impairments, either pre- or postoperatively, that
can occur with TLE. In particular, type 2 HS has been associated
with preserved declarative memory prior to surgery (12, 33)
although not in all surgical cohorts (48). These different ﬁndings
between series may relate to the relatively smaller numbers of type 2
HS cases available for study. In addition, loss of dentate gyrus (DG)
granule cells in TLE (12, 30) has also been linked with reduced pre-
operative memory capacity. There is marked plasticity and reorgan-
ization of the DG in HS/TLE exempliﬁed by the reorganization of
the mossy ﬁber pathway (40), alterations of hippocampal regenera-
tive capacity (11), reduction of calbindin protein in granule cells
(23), astroglial abnormalities (19), altered zinc signaling (38) as well
as neurodegeneration including tau accumulation (22), all of poten-
tial relevance to the memory dysfunction in HS/TLE.
Our aim was to better characterize patterns of HS, associated
regenerative and degenerative alterations and correlate these with
preoperative memory function and postoperative outcomes includ-
ing memory decline, in a large series of patients operated for TLE.
We included cases that were either typical ILAE type 1 or type 2
HS as well as a group that we considered to have indeterminate
patterns of sclerosis (between type 1 and 2), as judged by NeuN
qualitative evaluation. MAP2 shows more conﬂuent subﬁeld
immunolabeling in the normal CA4 of cell soma and dendritic net-
works. As the ILAE 2013 system is based on a qualitative assess-
ment of overall NeuN labeling rather than actual neuronal cell
counts, we hypothesized that MAP2 could provide a more sensitive
qualitative evaluation in these indeterminate HS cases. A further
aim was therefore to quantitate, compare and validate the useful-
ness of these markers for HS subtyping using a rapid automated
analysis method.
METHODS
The cases were selected from the UCL Epilepsy Society Brain and
Tissue Bank acquired over two decades (1994–2015). The study
has ethical approval and patients consented for research. Applying
current ILAE criteria for HS based on semiquantitative evaluation
of NeuN staining (8), we included 52 cases with type 1, 15 cases
with unequivocal type 2 HS and 18 indeterminate cases (Ind-HS)
where it was not possible to classify between type 1 and 2 HS
based on qualitative evaluation of neuronal loss on NeuN in CA4
using ILAE criteria (8). The type 2 and Ind-HS cases represented
all cases available for study in our archive, cases only being
excluded if there was a lack of consent for research or sufﬁcient tis-
sue was not available. In addition, we included seven TLE cases
with No-HS as a comparison for neuronal density measurements
only. The clinical features of the HS groups are presented in Table
1 and the No-HS cases in Supporting Information Table S1.
Immunostaining
In each case a representative formalin-ﬁxed and parafﬁn-embedded
tissue block was selected from the hippocampal resection which
showed maximal representation of all subﬁelds including the DG.
Sections were cut at 5 lm thickness and immunohistochemistry
staining was carried out using an antibody panel (see Supporting
Information Table S2 for antibodies, sources, dilutions and meth-
ods): MAP2, NeuN (neuronal loss), ZnT3 [for mossy ﬁber pathway
sprouting (13)] and AT8 (phosphorylated tau) was carried out on the
entire HS series and calbindin, olig2, MCM2 and nestin markers
(hippocampal reorganization/regeneration) were carried out on 40
type 1 HS cases which were selected to include equivalent numbers
with or without a preoperative memory deﬁcit to identify pathologi-
cal alterations that could be predictive of memory loss.
Quantitative analysis
All pathology measurements were carried out blinded to the cogni-
tive data and details of the quantitative methods are summarized in
Table 2. Semi-quantitative scores were carried out by two observers
with good agreement (Kappa index 0.8–0.9); for cases with dispar-
ity in the grade, the slide was reviewed by a third person and a con-
sensus was achieved.
Cognitive measures
Preoperative cognitive data was compared to retest data at 1 year
following surgery, as previously described (43) and were available
for the majority of patients from routine surgical evaluations under-
taken at the National Hospital. Memory was assessed with the List
Learning and Design Learning subtests from the Adult Memory &
Information Processing Battery prior to 2007 and its successor the
Brain Injury Rehabilitation Trust (BIRT) Memory and Information
Processing Battery from 2007. These measures have previously
been shown to be sensitive to hippocampal pathology (1). Naming
capacity was assessed using the graded naming test (GNT) (5), a
measure sensitive to dominant temporal lobe resections (9). Preop-
eratively patients were classiﬁed as having a moderate verbal or
visual memory deﬁcit if they scored 1 SD or more below average,
and as having a severe deﬁcit if they scored 2 SD or more below
average. A patient was classiﬁed as having experienced a postoper-
ative decline in verbal memory, visual memory and GNT capacity
if their postoperative scores declined more than would be expected
from retesting on the basis of the reliable change indices (with a
conﬁdence interval of 90%) (6).
Clinical data and statistical methods
The duration and age at onset of epilepsy, any initial precipitating
injuries (IPI) and outcomes following surgery were recorded. Sta-
tistical analysis was carried out between HS groups, pathology
measures, psychometric and clinical data using SPSS (version 21
for windows) and included nonparametric tests (Mann–Whitney
and Kruskall–Wallis tests) between HS groups and the MANOVA
for multivariate analysis of factors in relation to psychometric cate-
gories; P values of <0.05 were regarded as signiﬁcant.
RESULTS
Application of MAP2 in classifying
indeterminate HS subtypes
MAP2 highlighted better preservation of CA4 neuronal and
dendritic labeling in Ind-HS compared to type 1 HS cases
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(Figure 1A,B) with comparable intensity to type 2 HS (Figure
1C). By comparison, with NeuN labeling the CA4 neuronal
densities in Ind-HS cases appeared intermediate between type 1
and 2 on qualitative assessment alone (Figure 1D–F). Quantita-
tive and statistical analysis with whole slide scanning analysis
conﬁrmed that with NeuN, CA4 LI in Ind-HS was between type
Table 1. Clinical features of ILAE subtypes compared to patients with indeterminate HS. Abbreviations: GS5 secondary generalized seizures.
N5 the total number of cases in the group that data was available for.
Clinical group TYPE 1 HS TYPE 2 HS IND-HS
Number of cases 52 15 18
Gender Male/Female 22/30 5/10 9/9
Age of onset 11.6 (1–41) 11.6 (0–21) 16.25 (9-22)
Mean (range)
years
Age at surgery 35.6 (18–55) 35.4 (21–53) 27.34 (24–31)
Mean (range)
years
Side operated Left/right 29/23 8/7 6/12
Seizure types (% of cases) SPS 59.6 64.3 55.6
CPS 94.2 92.9 100
GS 78.8 85.7 72.2
IPI (% of cases) Seizure 53.8 * 50 44.4**
Head Injury 9.6 14.3 0
Other 11.5 0 5.6
None 21.2 35.7 44.4
Preoperative memory dysfunction (% of cases)
N5number of cases with deficit/total tested
Moderate Verbal function deficit (L/R) 53%† 54% 33%
(67%/36%) (62%/40%) (60%/20%)
N526/49 N5 7/13 N5 5/15
Severe Verbal function deficit 24.4% 23.1% 6.3%
N511/45 N5 3/13 N5 1/16
Moderate Visual function deficit (L/R) 50%† 69.2% 40%
(46%/55%) (62.5%/80%) (40%/40%)
N 5 24/48 N 5 9/13 N 5 6/15
Severe Visual function deficit 9.5% 33.3% 25%
N 5 2/21 N 5 2/6 N 5 1/4
Moderate deficit in naming
(L/R)
51.2% 76.9% 46.7%
(58%/42%) (100%/40%) (100%/20%)
N 5 22/43 N 5 10/13 N 5 7/18
Severe deficit in naming 27.9% 23.1% 33.3%
N 5 12/43 N 5 3/13 N 5 5/15
Postoperative memory decline in function (% of cases)
N5number of cases with deficit/total tested
Decline in verbal function 22% 22% 27%
N 5 8/37 N 5 2/9 N 5 4/15
Decline in visual function 13% 11% 13%
N 5 5/38 N 5 1/9 N 5 2/15
Decline in naming 26% 10% 7.1%
N 5 10/38 N 5 1/10 N 5 1/14
Outcome
SF (% of cases)
(Number of cases)
1 year 69% 50% 56%
(52) (14) (18)
2 year 60% 36% 56%
(50) (11) (18)
5 year 66% 44% 58%
(38) (9) (12)
10 year 69% 43% 20%
(13) (7) (5)
Initial precipitating injuries: “seizure” group includes a childhood seizure or Febrile Seizure; other category includes any other childhood event
including episode of encephalitis/meningitis.
In 3.8%* and 5.6%** of these cases indicated more than one type of IPI was reported. Partial seizures were grouped into simple (SPS) and
complex partial (CPS) in this dataset. The postsurgical outcome was classified using the ILAE system and in this table grouped as seizure free
(SF). There was no statistical difference between these clinical factors in the three selected groups.
†The type 1 HS cases were selected to include cases both with and without memory decline. For definitions of severe and moderate memory
deficits, refer to the main text.
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Table 2. Outline of the methods for quantitative and qualitative evaluation of each pathological feature in hippocampal sclerosis cases with
specified immunomarkers.
Measurement Method
NeuN and MAP2 hippocampal
subfield analysis for neuronal loss
Quantitative evaluation:
1. Sections scanned at x40 and digitized (Leica SCN400 scanner,
Leica Microsystems, UK)
2. Six regions of interest (ROIs) were manually defined using Definiens
Developer XD 64 software (Definiens AG Munich, Germany): dentate
gyrus, subiculum, CA4*, CA3, CA2 and CA1†
3. Definiens software was trained to automatically detect immunostained
structures corresponding to (i) neuronal nuclei (NeuN) or (ii)
neuronal cell body and dendrites (MAP2)
4. Labeling index (LI) [percentage of immunostained area/field
fraction‡] for each subfield calculated
MAP2 labeling of basal
dendrites on granule cells
Semiquantitatively scored:
1. Rare dendrites
2. Moderate numbers of granule cells with basal dendrites
3. Many/majority of granule cells have basal dendrites
Olig2 and MCM2 in dentate gyrus Quantitative evaluation:
1. Section tiled at 32 magnification (Nikon eclipse microscope)
using Image Pro Plus (Media Cybernetics, Cambridge, UK)
2. The dentate gyrus was outlined and images captured at 340
representing this entire area (mean 55 fields/case; range 23–111)
3. Positively labeled nuclei were tagged and the mean number of cells/lm2 calculated
Nestin immunolabeling Quantitative evaluation:
1. Slides scanned as for NeuN (above)
2. Using Definiens software, the LI was quantified in four nonoverlapping
ROI: granule cell layer, subgranular zone, CA4 and CA1
ZnT3 evaluation for Mossy
fiber pathway sprouting
Semiquantitatively scored:
1. Mossy fiber pathway sprouting in the molecular layer was
semiquantified using a three-point scale:
0: no sprouting/labeling
1: weak or focal labeling
2: intense labeling
2. The presence of a residual mossy fiber pathway§:
0–2 (as above)
3. Axonal sprouting in the subgranular zone:
0–2 (as above)
Calbindin in granule cell layer Semiquantitatively scored:
0: total loss/absent expression in granule cells
1: severe loss/rare labeled granule cells
2: partial loss/approximately half granule cells labeled¶
3: retained/virtually all granule cells labeled
AT8 labeling for hippocampal
phosphorylated tau
Semiquantitatively scored:
1. Six point “modified Braak” tau scoring scale, in any hippocampal
subfield, dentate gyrus, subiculum, alveus/white matter:
0: negative
1: rare grains
2: rare threads
3: few grains or threads
4: moderate neuropil threads/neuronal labeling
5: marked deposition**
*For CA4 ROI care was taken to exclude the basal dendrite zone of the granule cells in MAP2 sections.
†In the majority of cases all six regions were acquired.
‡Labeling index (LI) refers to the percentage/index of immunostained area, that is, the fraction of each digitized high power field that is immuno-
labeled with an intensity above the set threshold.
§Synaptic-like positive labeling in CA4 and CA3.
¶The pattern of positive labeling restricted to the dispersed granule cells only, as previously reported in HS (2, 26) was also noted if present or not.
**AT8 labeling of level 5 was equivalent to Braak stage IV in hippocampus.
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1 and 2 HS and statistically different from both (P< 0.0001)
(Figure 1G–I). With MAP2, however, CA4 LI in Ind-HS cases
was not statistically different to type 2 HS (P5 0.07) but differ-
ent from type 1 HS (P5 0.01) (Figure 1J–L). Furthermore,
compared to LI in No-HS cases, there was a mean relative
reduction of MAP2 LI in CA4 of 36% in type 1 HS compared to
only 8% in Ind-HS and 0% in type 2 HS. Ratios of CA4/CA1 LI
for NeuN (Figure 1M) and MAP2 (Figure 1N) also conﬁrmed
the utility of MAP2 in statistically classifying Ind-HS as similar
to type 2 HS.
Figure 1. Hippocampal sclerosis (HS) patterns with NeuN and MAP2.
Comparison of labeling in type 1 HS (A,D), type 2 HS (C,F) and
indeterminate HS (Ind-HS) (B,E) for MAP2 (A,B,C) and NeuN
(D,E,F). MAP2 and NeuN both clearly demonstrated the neuronal loss
in CA1 in all HS subtypes. Arrow heads indicate regions with patchy
neuronal loss in CA4 and the hilus in Ind-HS, particularly in the subgra-
nular zone, but with overall strong CA4 labeling in MAP2 (B). G–L.
Bar graphs of the labeling index (LI) for NeuN (G,H,I) and MAP2
(J,K,L) between subtypes of HS. G. There was a significant differ-
ence in NeuN LI between type 1 and type 2 HS cases in this series in
all subfields except for CA1 and the subiculum confirming the distinct
patterns of neuronal loss (P< 0.001 to P< 0.0001). H. Comparison of
type 1 and Ind-HS with NeuN showed significant differences in the LI
in only CA4 (P< 0.0001) whereas I between type 2 and Ind-HS, differ-
ences were observed for all subfields except CA1 and the subiculum
(P< 0.006 to P< 0.0001). J. MAP2 LI also showed significant differ-
ences between type 1 and type 2 for CA4 (P< 0.0001). K. Compari-
son of type 1 and Ind-HS, with MAP2 the LI showed differences in
CA4 (P50.01) whereas (L) there were no significant differences
between type 2 and Ind-HS cases for any subfield on MAP2. M. Box
plots of mean CA4/CA1 ratios for NeuN are highest in type 2 HS with
significant differences between all three groups whereas MAP2 classi-
fies Ind-HS as similar to type 2 HS. Statistical differences are shown
as (*P< 0.01–0.001, **P< 0.0001). The values for the dentate gyrus
(DG), labeling index in G to I are shown as 31021 for presentation
purposes. Bar for A to F is 1 mm.
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Cognitive performance in relation to HS type
and hippocampal neuronal loss
Moderate deficit
Cases with moderate preoperative verbal, visual memory and GNT
deﬁcits were represented in both type 2 and Ind-HS groups (in addi-
tion to the selected type 1 HS group) (Table 1); although deﬁcits were
noted more frequently in type 2 than Ind-HS for all three domains,
there were no signiﬁcant differences between these two groups. Mod-
erate deﬁcits in verbal memory were more common in left than right
sided resections (63% vs. 37%) (P5 0.004) and similarly for GNT
deﬁcits (65% vs. 35%) (P5 0.002) over all cases. A signiﬁcant left
sided predominance in cases with GNT deﬁcits was also noted in type
2 HS (P5 0.016) and Ind-HS (P5 0.013) with all left sided resec-
tions in these HS groups showing this deﬁcit (Table 1).
Severe deficit
Cases with severe preoperative verbal, visual memory and GNT
deﬁcits were represented in both type 2 and Ind-HS groups, but
with no signiﬁcant difference between groups (Table 1).
Cognitive decline
Verbal memory decline was present in 32% (14/61), visual memory
decline in 13% (8/62) and a decline in naming in 19% (12/62) over
all HS cases that had retesting 1 year postoperatively; cases with
memory decline in each domain were represented in type 1, type 2
and Ind-HS with no signiﬁcant differences between groups (Table 1).
Comparison with pathology measures showed signiﬁcant associ-
ations between lower mean NeuN or MAP2 LI in CA1, CA4, DG
and subiculum subﬁelds with moderate or severe preoperative
memory deﬁcits in all cases or HS subtypes as summarized in
Table 3. Multivariate analysis showed a signiﬁcant association of
these pathology variables with moderate verbal memory deﬁcits.
For memory decline, the only signiﬁcant observation was higher
mean MAP2 LI in the subiculum in cases with naming decline
postoperatively (Table 3).
DG pathology in HS types and cognitive
measures
ZnT3
Mossy ﬁber pathway sprouting with ZnT3 was observed in all HS
types (Figure 2D,E). Intense ZnT3 mossy ﬁber pathway sprouting
was more frequently observed in type 1 than type 2 HS cases (55%
vs. 29%, respectively) with a trend for a signiﬁcant difference
between these groups (P5 0.05) (Figure 2H); there were no differ-
ences in mossy ﬁber pathway sprouting patterns between type 1 and
Ind-HS groups. A residual mossy ﬁber pathway was signiﬁcantly
Table 3. Results of statistical analysis between pathology measures and memory deficits. Abbreviation: MRA5multiple regression analysis
performed with SPSS to predict the effect of the multiple variables on the memory deficit.
Cognitive domain Subfield Pathology
measurement
Mean LI/value* in
cases with deficit/
decline (SD) N 5
number of cases
Mean LI/value* in
cases without deficit/
decline (SD)
N5 number of cases
Significance
Verbal memory deficit (moderate) CA1 NeuN LI 0.008 (0.006) N 5 35 0.01 (0.008) N5 40 P50.04 (all HS)
0.007 (0.004) N524 0.012 (0.01) N5 22 P50.019 (type 1 HS)
CA4 MAP2 LI 0.3 (0.2) N 5 37 0.4 (0.18) N 5 35 P50.04 (all HS)
0.26 (0.16) N 5 25 0.37 (0.2) N 5 20 P50.05 (type 1 HS)
DG Basal dendrites* 1.51 (0.73) N 5 37 1.92 (0.8) N 5 38 P50.025 (all HS)
MRA All above P50.016 (R25 0.15) (all HS)
Visual memory deficit (moderate) CA1 MAP2 LI 0.2 (0.12) N 5 31 0.3 (0.15) N 5 36 P50.042
Naming deficit (moderate) DG NeuN LI 0.1 (0.06) N 5 20 0.14 (0.07) N 5 20 P50.03 (Type 1 HS)
0.25 (0.09) N 5 10 0.38 (0.03) N 5 3 P50.02 (Type 2 HS)
CA4 MAP2 LI 0.31 (0.05) N 5 7 0.5 (0.15) N 5 6 P50.008 (Ind-HS)
MRA All above Not significant (all HS);
P50.03 (R250.47) (Ind-HS)
Verbal memory deficit (severe) DG Residual MFP* 1.27 (0.6) N 5 15 1.56 (0.6) N 5 57 P50.013 (all HS†)
Visual memory deficit (severe) Subiculum MAP2 LI 0.7 (0.06) N 5 5 0.83 (0.08) N 5 22 P50.008 (all HS†)
Naming deficit (severe) DG NeuN LI 0.12 (0.08) N 5 20 0.16 (0.09) N 5 50 P50.05 (all HS†)
Verbal memory decline None
Visual memory decline CA4 Nestin LI 0.23 (0.06) N 5 3 0.1 (0.06) N 5 24 P50.016
Naming decline Subiculum MAP2 LI 0.78 (0.13) N 5 11 0.64 (0.21) N 5 43 P50.03 (all HS)
AT8* 55% N 5 6/11 22% N 5 10/45 P50.035 (all HS)
DG AT8* 45.5% N 5 5/11 11% N 5 5/45 P50.008 (all HS)
MRA All above P50.008 (R25 0.2)
Pathology factors showing significant differences between the presence or absence of deficits in each memory domain are listed and the mean
values shown, including the labeling index (LI) of immunostaining for NeuN or MAP2 (except for pathology factors indicated with an asterisk,
where the semiquantitative score scales are detailed in supplementary methods).
†In cases with the severe memory deficits it was not possible to analyze data further for HS subtypes be caused by the small numbers with a
severe deficit in each group.
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better preserved in both type 2 HS (P5 0.003) and Ind-HS cases
(P5 0.01) than type 1 HS (Figure 2A–C,I). Labeling of sprouted
ﬁbers in the subgranular zone with ZnT3 (Figure 2D,E) was more
prevalent in type 2 than type 1 HS (P5 0.01). The presence of basal
dendrites on granule cells as visualized with MAP2 varied dramati-
cally between HS cases (Figure 2F,G); although more prevalent in
type 1 HS the presence of basal dendrites was not signiﬁcantly dif-
ferent from type 2 and Ind-HS based on semiquantitative scores
Figure 2. Mossy fiber pathway, granule cell basal dendrites in
relation to hippocampal sclerosis (HS) type and memory function. A–
E. ZnT3; F–G. MAP2. A. Intense labeling of a retained or normal
mossy fiber pathway (MFP) trajectory is shown and absent sprouting.
B. shows moderate labeling of the normal MPF as well as sprouting
in the molecular layer and in C the pathway is indistinct (the two
arrowheads indicate CA3 and one arrowhead CA4 in the MFP in each
figure). D. ZnT3 labeling in the subgranular zone (SGZ) is present
(arrow) with weak MFP sprouting in the molecular layer and a weak
residual MFP in CA4 (arrowhead). E. shows more intense MFP
sprouting in the molecular layer with ZnT3 also showing some
sprouted fibers in the SGZ (arrow). F. Basal dendrites on granule cells
are highlighted with MAP2 and in this case, are very numerous
(arrows) forming a mesh of processes in the SGZ. G. In other cases,
rarer granule cells (arrow) are observed to have basal dendrites. H.
Bar chart of the presence of MFP sprouting in the molecular layer
between HS types showing differences between type 1 and type 2
HS (*P5 0.05). I. The presence of a better preserved or residual MFP
also showed significant differences between HS groups with better
preservation in non-type 1 HS cases (*P5 0.01, **P50.003). J. The
presence and density of basal dendrites on granule cells showed
some variation between HS groups, but the differences were not sig-
nificant. (Of note in the three bar graphs H to J, the values for Ind-HS
group are always between observed values for type 1 and type 2 HS).
K. In all HS/TLE cases, the presence of a better preserved or residual
MFP (weak1 intense) was associated with a lack of severe preopera-
tive verbal memory deficit (*P5 0.013). L. The presence of basal den-
drites in granule cells was associated with the lack of moderate
verbal memory deficit (*P50.025). Bar is equivalent to approximately
1 mm in A to C, 100 microns in D and E and 50 lm in F and G.
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(Figure 2I). There was a strong positive correlation in all HS cases
between the presence of basal dendrites on granule cells and ZnT3
sprouted ﬁbers in the subgranular zone (P< 0.0001). Statistical anal-
ysis showed an association between severe preoperative verbal
memory deﬁcit and lack of a preserved mossy ﬁber pathway (Table
3, Figure 2K) and moderate preoperative verbal memory deﬁcit and
the presence of basal dendrites on granule cells (Table 3, Figure 2L).
Calbindin
Total loss of calbindin expression in granule cells was noted in
35%, severe loss in 32.5%, partial loss in 30% and no loss in 2.5%
of all cases (Figure 3A–C). The pattern of restricted calbindin
expression in dispersed granule cells only was present in 30% (Fig-
ure 3D) (2, 26) which signiﬁcantly correlated with MAP2 basal
dendrites on granule cells (P5 0.002) and ZnT3 in the subgranular
zone (P5 0.001). There were no statistical associations between
calbindin expression patterns and memory deﬁcits (Supporting
Information Table S3).
AT8
In 35% of cases there was no evidence of hippocampal phosphoryl-
ated tau (score 0). In 53.3% of cases rare grains or threads were
noted (score 1 and 2) (Figure 3E) with a few AT8 threads in 10.4%
(score 3) and moderate AT8-positive tau load in 1.3% of cases
Figure 3. Dentate granule cell layer: evidence of regenerative and
degenerative pathology changes. A–D. Calbindin immunohistochemistry
varied between cases and was semiquantified as A. Preserved
expression in granule cells and their apical dendrites, B. Partial loss of
expression in approximately half of granule cells, C. Virtual total loss of
expression with only interneurons in CA4 showing positivity. D. A
frequent pattern in HS/TLE is calbindin expression in the dispersed or
migrated cell types whereas the basal granule cells are calbindin
negative. There was no statistical association between calbindin
expression patterns and memory deficit. E–H AT8/phosphorylated tau
immunohistochemistry, common patterns were E. Occasional grains
and threads in the molecular layer, F. More frequent threads and
positive neurones in the subiculum, G. Labeling of axons in the
hippocampal white matter, H. Tau positive neurones in the margins of
CA1 subfield: The presence of AT8 in the dentate gyrus and subiculum
was significantly associated with memory decline postoperatively.
I. Olig2 immunohistochemistry: Distinct labeling of a proportion of
small nuclei in the dentate gyrus, some in a satellite position in relation
to the granule cells. J. MCM2 immunohistochemistry: Less frequent,
small immature nuclei were present through the dentate gyrus but no
labeling of mature granule cells was seen. The density of olig2 and
MCM2 positive cells declined, but not significantly, with memory
deficit. K–L. Nestin immunohistochemistry: K. Labeling of multipolar
cells was most prominent in the subgranular zone and in CA4;
L. Illustration of occasional nestin-expressing cells in the molecular
layer. There was a positive correlation between nestin labeling in CA4
in patients with visual memory decline. Bar is equivalent to approxi-
mately 100 lm in A to D, 20 lm in E, G–J and 75 lm in F, K and L.
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(score 4); there was no case with a score 5. AT8 was present in the
subiculum (47%) (Figure 3F), the DG molecular layer (37%) (Fig-
ure 3E) and axonal-like ﬁbers in the parahippocampal gyrus white
matter (20%) (Figure 3G); labeling was noted in the alveus in 9
cases and in 10 cases prominent labeling of horizontal neurones
and ﬁbers in the outer part of CA1 pyramidal cell layer (and CA2)
was noted (Figure 3H). The presence of AT8 in the DG and subicu-
lum was signiﬁcantly associated with naming decline 1 year post-
operatively (Table 3).
Olig2 and MCM2
Labeling was restricted to the nuclei of small, immature, round to
ovoid cells in the DG (Figure 3I,J); some were occasionally noted
in a “satellite” position in relation to mature granule cell neurones.
The density of olig2 and MCM2 positive cells were lower in HS
cases with severe preoperative verbal and visual memory function
but not signiﬁcantly different to cases without deﬁcit (Supporting
Information Table S3).
Nestin
Expression in the DG, apart from in the endothelium, was virtually
restricted to multipolar cells in the subgranular zone and more
prominently in CA4 (Figure 3K); occasional multipolar cells in the
molecular layer were seen in some cases (Figure 3L). There was a
positive correlation between nestin LI in CA4 in patients with vis-
ual memory decline at 1 year (P5 0.016) but not for other hippo-
campal ROI (Table 3).
Clinical correlations and outcome
There was no signiﬁcant difference in the epilepsy history between
type 1, 2 and Ind-HS groups, in regard to age of onset and IPI his-
tory, although a lack of a reported IPI was more frequent in the
atypical/non-type 1 HS cases (Table 1). Complete seizure-freedom
was less frequent for type 2 compared to type 1 HS, with Ind-HS
cases falling between these two groups at each period of follow-up
from 1 to 5 years; however, these differences between the groups
were not signiﬁcant (Table 1). There was a correlation between the
modiﬁed tau score (R25 0.075) and age at surgery, but not with
other clinical factors including age of onset of epilepsy or IPI type
including history of head injury.
DISCUSSION
HS is the most frequent pathology in TLE and classiﬁcation of sub-
types is currently recommended by the ILAE as it may inform on
different clinical syndromes, outcomes and co-morbidities, includ-
ing memory impairment (8). In this study, we have shown that
additional quantitative evaluation of MAP2 enables the classiﬁca-
tion of equivocal or indeterminate cases, which seem to fall
between type 1 and 2 HS based on current ILAE criteria, as being
statistically similar to type 2 HS. Nevertheless, memory deﬁcits
present before surgery in our cohort do not align with one HS type
but correlate with several pathology factors including neuronal loss
in several subﬁelds and mossy ﬁber reorganization. Postoperative
memory decline was associated with neurodegenerative and regen-
erative pathological alterations. These ﬁndings suggest that
multifactorial patho-mechanisms could be operational in the mem-
ory impairments associated with HS/TLE.
MAP2 highlights both dendritic labeling as well as the neuronal
soma, and is conﬁrmed in this study as a useful adjunct to NeuN
for the more sensitive evaluation of neuronal preservation in equiv-
ocal cases, particularly in subﬁelds as CA4 with lower neuronal
densities. We propose that introduction of MAP2 staining in addi-
tion to NeuN in equivocal cases can help in routine evaluation of
sclerosis patterns. Qualitative impressions of MAP2 were supported
by quantitative analysis in this study employing whole slide scan-
ning image analysis systems which are being increasingly applied
in routine diagnostic practice (24). This technique has advantages
over both subjective semiquantitative as well as other quantitative
methods (12, 41), as the entire hippocampus is evaluated and rap-
idly, automatically analyzed in an unbiased fashion. Based on
MAP2 quantitative analysis, Ind-HS were statistically similar to
type 2 HS whereas with NeuN quantitation they fell between type
1 and 2 HS. Interestingly, mossy ﬁber pathway reorganization
which differed between 1 and 2 HS groups was intermediate in
Ind-HS cases which could suggest a pathological continuum in the
process of HS. Furthermore, previous studies have reported fewer
seizure-free outcomes following temporal lobe resections in ILAE
type 2 compared to type 1 HS (7, 14, 28). In our series, which
included a large number of ILAE type 2 cases, lower rates of
seizure-free outcomes were also noted and although not statistically
different from type 1 HS cases, the outcomes for the Ind-HS group
were again noted to be intermediate between type 1 and 2.
The hippocampus has a central role in episodic memory (35)
and memory impairment frequently accompanies HS (18, 20) with
a dominant role for the left intact hippocampus in verbal memory
and the right with visual-spatial memory, as also reﬂected in this
current series. Temporal lobe surgery has offered a unique opportu-
nity to correlate pathology, in particular the severity and distribu-
tion of hippocampal subﬁeld neuronal loss and gliosis, with any
memory dysfunction, in an aim to elucidate normal mnemonic
pathways and networks and their potential disruption and reorgan-
ization in epilepsy (3, 10, 12, 30, 46). Previous quantitative studies
have reported a correlation between reduced left CA1 neuronal
densities and preoperative verbal memory deﬁcits (3), a pre-
eminent role for the loss of granule cells and memory dysfunction
(12, 30) while other studies showed a correlation with overall neu-
ronal loss across hippocampal subﬁelds (46). In the present study,
we have shown correlations between neuronal loss assessed with
whole slide scanning on NeuN and MAP2 in DG, CA1, CA4 and
subiculum subﬁelds and moderate to severe preoperative memory
dysfunction. We failed to conﬁrm loss restricted to a single subﬁeld
associating with either a memory deﬁcit or decline and multivariate
analysis also supported a synergistic contribution of multiple
pathology factors to memory dysfunction.
Recent studies have also implicated associations between ILAE
HS type and memory function. In a series of 13 patients with ILAE
type 2 HS, a lack of dysfunction in declarative memory capacity, as
assessed by intracarotid amobarbital (WADA) testing in addition to
verbal memory tests, was observed; this suggested functional integ-
rity of hippocampal memory networks despite neuronal depletion
of the CA1 sector (10, 12). This ﬁnding was supported by a subse-
quent report of 36 HS/TLE patients in which type 2 HS cases were
over-represented in patients with normal memory scores (33)
although disputed in a further report of six type 2 HS cases who all
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had impaired memory function (48). A “subordinate” role of CA1
in hippocampal memory circuitry is thus still open to debate. The
relatively small number of type 2 cases in each of these series
might explain these differences reported as well as differences in
memory test designs. In our series, only two patients had had a
WADA test, a procedure no longer used at our institute to assess
memory function. We included all the available cases of type 2 HS
from our institute and conﬁrmed preoperative memory deﬁcits
were frequent for visual and verbal memory domains with the
anticipated left vs. right lateralization patterns. Our ﬁndings support
that intact memory function is not always present in type 2 HS.
ZnT3 has been recently employed as a robust marker of the
mossy ﬁber pathway and its re-organization in epilepsy (13). Zinc
is also known to have important modulatory effects on synaptic
transmission (25) and a role of ZnT3 in cognitive impairment in
neurodegenerative diseases has been proposed (39, 45). Using this
marker in our series, mossy ﬁber pathway sprouting was a common
ﬁnding with some differences between HS groups including a more
prominent residual mossy ﬁber pathway in type 2 and Ind-HS than
type 1 HS. Furthermore, there was an association between loss of
the normal mossy ﬁber pathway and preoperative verbal memory
deﬁcit, suggesting that integrity of this anatomical pathway is
involved in functional memory circuits. Coras et al, also noted bet-
ter anatomical preservation of CA4/3 myelinated ﬁbers connecting
to the ﬁmbria and subiculum in HS type 2 patients with intact
memory functions (12). We also noted a great variability in the
density of basal dendrites on granule cells between HS cases as
highlighted with MAP2. It is known that the number of basal den-
drites are increased in HS/TLE and were present in 40% of granule
cells in a previous Golgi study (44). Similarly, in experimental
models, basal dendrites are a feature of immature granule cells,
their numbers increase following seizures and they are innervated
by mossy ﬁbers and potentially contribute to recurrent excitatory
circuits (29). We noted that the presence of basal dendrites strongly
correlated with ZnT3 labeling of mossy ﬁbers in the subgranular
zone, which is in keeping with these experimental ﬁndings. Our
observation of lower densities of basal dendrites on granule cells in
patients with preoperative memory deﬁcit could also imply their
contribution to anatomical memory circuits in the damaged hippo-
campus. In addition, basal dendrites as a surrogate marker of newly
generated or immature granule cells could support the concept of
an impaired regenerative capacity/plasticity in HS patients with
memory deﬁcits.
The subgranular zone is one of the main regenerative sites in the
adult human brain with estimates of 700 new cells added per day
(34). Seizures are known to inﬂuence progenitor cell turnover (29)
and previous in-vitro studies on human epilepsy tissues have corre-
lated loss of granule cell proliferative capacity with memory dys-
function (11). In the current series, we selected equal numbers of
classical or type 1 HS both with and without memory deﬁcits in an
aim to tease out any pathological differences in DG regenerative
capacity that could be measured in ﬁxed tissue sections. We uti-
lized cell cycle marker MCM2 to measure overall cell replicative
capacity in the hippocampus and olig2 as a marker of oligodendro-
cyte progenitor cells, previously shown to be the largest population
of proliferating cells in tissues from focal epilepsy (16). Calbindin
is not expressed in immature granule cells and reduced calbindin
expression in granule cells is a frequent observation in TLE, partic-
ularly in less mature basal granule cells (1, 2, 26). Furthermore,
lower calbindin levels in granule cells have been postulated to
inﬂuence memory capacity, being depleted in Alzheimer’s disease
(36) and a loss of calbindin has been previously shown in TLE to
correlate with verbal memory dysfunction (23). In this current
study, although differences were noted with our methods, we were
unable to conﬁrm a signiﬁcant correlation between olig2, MCM2
and calbindin labeling with pre- or postoperative memory dysfunc-
tion in type 1 HS.
Further decline in memory following temporal lobe surgery is
reported to occur in up to 25%, with older patients being particu-
larly vulnerable (21, 43). A better-preserved hippocampus has been
shown to be predictive of greater postoperative decline in verbal
memory function (47) and more signiﬁcant postoperative memory
declines have been reported with ILAE type 2 HS (12) or better
preserved CA1 (3). In terms of quantitative conﬁrmation of
regional neuronal preservation in the present study, we identiﬁed a
statistical association between MAP2 labeling only in the subicu-
lum and naming decline at 1 year. However, we also identiﬁed an
association between the presence of phosphorylated tau pathology
in the subiculum and DG and a postoperative decline in naming.
The tau load was overall low in this predominantly young adult
cohort but correlated with age at surgery and is unlikely to repre-
sent either a primary tauopathy or be relevant to the cause of epi-
lepsy. Previous surgical (31, 37) as well as post-mortem studies in
long-term epilepsy (42) support an age-accelerated deposition of
tau, with some patterns potentially related to brain injury. Enhanced
accumulation of p-tau has been shown in the molecular layer, gran-
ule cells and mossy ﬁbers in association with seizures in Alzhei-
mer’s disease transgenic mouse models (49) and tau accumulation
is modulated by synaptic activity in experimental systems (37). We
have also previously shown “epilepsy-speciﬁc” patterns of tau
accumulation in the hippocampus in some patients over 50 years
old at surgery, including early involvement of the DG (37). This
study therefore highlights the potential vulnerability of some
younger adults with epilepsy to a secondary tauopathy, which may
predispose to postoperative memory decline following surgery.
Reactive astrogliosis is a prominent component of HS and plas-
ticity of glial cell populations and functional changes are consid-
ered to contribute to disease mechanisms in epilepsy (4, 44)
including potential effects on memory (19, 32). Glial cells exceed
brain cells in their complexity, diversity and number, with roles for
glial transmitters in memory, including long term memory consoli-
dation (15, 27) and spatial memory (17). Previous studies address-
ing glial populations in relation to memory in HS/TLE have
utilized GFAP (3) and showed no correlation between glial density
in any subﬁeld and preoperative neuropsychology test scores. Nes-
tin selectively labels a subset of immature glial cells in the subgra-
nular zone of the hippocampus which contribute to adult
neurogenesis (37); it is also an intermediate ﬁlament that is transi-
ently re-expressed in reactive, proliferating glia at injury sites. We
observed that nestin-positive glia in type 1 HS had restricted distri-
bution and were more prominent in hilar subgranular zone in HS
cases; furthermore, their density was inversely linked to visual
memory decline postoperatively.
The limitations of this study include the relatively small numbers
of type 2 and Ind-HS cases compared to type 1 HS cases. Although
the surgical specimens are processed following standard laboratory
protocols and similar ﬁxation times, we cannot exclude that minor
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variations could inﬂuence overall immunostaining intensity effect-
ing labeling index measurements between cases.
In conclusion, we have shown that MAP2 is a useful adjunct to
NeuN in the evaluation of neuronal preservation in CA4 in equivo-
cal, indeterminate HS cases, suggesting that these cases more
closely align with type 2 HS. Nevertheless, HS type in our series
was not predictive of memory dysfunction or decline, which associ-
ated instead with multiple pathological factors, including neuronal
and hippocampal pathway integrity, regenerative capacity and
degenerative changes.
ACKNOWLEDGMENTS
This work is supported by the Medical Research Council (grant
MR/JO127OX/1). This work was undertaken at UCLH/UCL who
received a proportion of funding from the Department of Health’s
NIHR Biomedical Research Centres funding scheme. The Epilepsy
Society Brain and Tissue Bank at UCL is funded by the Epilepsy
Society. APJ and EMTY are supported by CNPq (Conselho Nacio-
nal de Desenvolvimento Cientıﬁco e Tecnologico). ZM was sup-
ported by funding from the European Union’s Seventh Framework
Program (FP7/2007-2013) under grant agreement number 602102
(EPITARGET).
CONFLICT OF INTEREST
All authors have no conﬂict of interest to declare.
REFERENCES
1. Abraham H, Veszpremi B, Kravjak A, Kovacs K, Gomori E, Seress L
(2009) Ontogeny of calbindin immunoreactivity in the human
hippocampal formation with a special emphasis on granule cells of the
dentate gyrus. Int J Dev Neurosci 27:115–127.
2. Abraham H, Richter Z, Gyimesi C, Horvath Z, Janszky J, Doczi T,
Seress L (2011) Degree and pattern of calbindin immunoreactivity in
granule cells of the dentate gyrus differ in mesial temporal sclerosis,
cortical malformation- and tumor-related epilepsies. Brain Res 1399:
66–78.
3. Baxendale SA, Van Paesschen W, Thompson PJ, Duncan JS, Harkness
WF, Shorvon SD (1998) Hippocampal cell loss and gliosis:
relationship to preoperative and postoperative memory function.
Neuropsychiatry Neuropsychol Behav Neurol 11:12–21.
4. Bedner P, Steinhauser C (2013) Altered Kir and gap junction channels
in temporal lobe epilepsy. Neurochem Int 63:682–687.
5. Bird CM, Cipolotti L (2007) The utility of the recognition memory test
and the graded naming test for monitoring neurological patients. Br J
Clin Psychol 46:223–234.
6. Bird CM, Papadopoulou K, Ricciardelli P, Rossor MN, Cipolotti L
(2004) Monitoring cognitive changes: psychometric properties of six
cognitive tests. Br J Clin Psychol 43:197–210.
7. Blumcke I, Pauli E, Clusmann H, Schramm J, Becker A, Elger C et al
(2007) A new clinico-pathological classiﬁcation system for mesial
temporal sclerosis. Acta Neuropathol 113:235–244.
8. Blumcke I, Thom M, Aronica E, Armstrong DD, Bartolomei F,
Bernasconi A et al (2013) International consensus classiﬁcation of
hippocampal sclerosis in temporal lobe epilepsy: a Task Force report
from the ILAE Commission on Diagnostic Methods. Epilepsia 54:
1315–1329.
9. Bonelli SB, Thompson PJ, Yogarajah M, Vollmar C, Powell RH,
Symms MR et al (2012) Imaging language networks before and after
anterior temporal lobe resection: results of a longitudinal fMRI study.
Epilepsia 53:639–650.
10. Coras R, Blumcke I (2015) Clinico-pathological subtypes of
hippocampal sclerosis in temporal lobe epilepsy and their differential
impact on memory impairment. Neuroscience 309:153–161.
11. Coras R, Siebzehnrubl FA, Pauli E, Huttner HB, Njunting M, Kobow
K et al (2010) Low proliferation and differentiation capacities of adult
hippocampal stem cells correlate with memory dysfunction in humans.
Brain 133:3359–3372.
12. Coras R, Pauli E, Li J, Schwarz M, Rossler K, Buchfelder M et al
(2014) Differential inﬂuence of hippocampal subﬁelds to memory
formation: insights from patients with temporal lobe epilepsy. Brain
137:1945–1957.
13. Crevecoeur J, Kaminski RM, Rogister B, Foerch P, Vandenplas C,
Neveux M et al (2014) Expression pattern of synaptic vesicle protein 2
(SV2) isoforms in patients with temporal lobe epilepsy and
hippocampal sclerosis. Neuropathol Appl Neurobiol 40:191–204.
14. de Lanerolle NC, Kim JH, Williamson A, Spencer SS, Zaveri HP, Eid
T, Spencer DD (2003) A retrospective analysis of hippocampal
pathology in human temporal lobe epilepsy: evidence for distinctive
patient subcategories. Epilepsia 44:677–687.
15. Fields RD, Araque A, Johansen-Berg H, Lim SS, Lynch G, Nave KA
et al (2014) Glial biology in learning and cognition. Neuroscientist 20:
426–431.
16. Geha S, Pallud J, Junier MP, Devaux B, Leonard N, Chassoux F et al
(2010) NG21/Olig21 cells are the major cycle-related cell population
of the adult human normal brain. Brain Pathol 20:399–411.
17. Hassanpoor H, Fallah A, Raza M (2014) Mechanisms of hippocampal
astrocytes mediation of spatial memory and theta rhythm by
gliotransmitters and growth factors. Cell Biol Int 38:1355–1366.
18. Helmstaedter C, Elger CE (2009) Chronic temporal lobe epilepsy: a
neurodevelopmental or progressively dementing disease?. Brain 132:
2822–2830.
19. Henneberger C, Papouin T, Oliet SH, Rusakov DA (2010) Long-term
potentiation depends on release of D-serine from astrocytes. Nature
463:232–236.
20. Hermann B, Seidenberg M (2007) Epilepsy and cognition. Epilepsy
Curr 7:1–6.
21. Hermann BP, Seidenberg M, Dow C, Jones J, Rutecki P, Bhattacharya
A, Bell B (2006) Cognitive prognosis in chronic temporal lobe
epilepsy. Ann Neurol 60:80–87.
22. Kandratavicius L, Monteiro MR, Hallak JE, Carlotti CG Jr, Assirati JA
Jr, Leite JP (2013) Microtubule-associated proteins in mesial temporal
lobe epilepsy with and without psychiatric comorbidities and their
relation with granular cell layer dispersion. BioMed Res Int 2013:960126.
23. Karadi K, Janszky J, Gyimesi C, Horvath Z, Lucza T, Doczi T et al
(2012) Correlation between calbindin expression in granule cells of the
resected hippocampal dentate gyrus and verbal memory in temporal
lobe epilepsy. Epilepsy Behav 25:110–119.
24. Liu JY, Ellis M, Brooke-Ball H, de Tisi J, Eriksson SH, Brandner S
et al (2014) High-throughput, automated quantiﬁcation of white matter
neurons in mild malformation of cortical development in epilepsy. Acta
Neuropathol Commun 2:72.
25. Marger L, Schubert CR, Bertrand D (2014) Zinc: An underappreciated
modulatory factor of brain function. Biochem Pharmacol 91:426–435.
26. Martinian L, Catarino CB, Thompson P, Sisodiya SM, Thom M (2012)
Calbindin D28K expression in relation to granule cell dispersion,
mossy ﬁbre sprouting and memory impairment in hippocampal
sclerosis: a surgical and post mortem series. Epilepsy Res 98:14–24.
27. Moraga-Amaro R, Jerez-Baraona JM, Simon F, Stehberg J (2014)
Role of astrocytes in memory and psychiatric disorders. J Physiol
108:240–251.
Prada Jardim et al Characterising subtypes of hippocampal sclerosis and reorganization
Brain Pathology •• (2017) ••–••
VC 2017 International Society of Neuropathology
11
28. Na M, Ge H, Shi C, Shen H, Wang Y, Pu S et al (2015) Long-term
seizure outcome for international consensus classiﬁcation of
hippocampal sclerosis: a survival analysis. Seizure 25:141–146.
29. Parent JM, Kron MM (2012) Neurogenesis and epilepsy. In: Jasper’s
Basic Mechanisms of the Epilepsies. JL Noebels, M Avoli, MA
Rogawski, RWOlsen, AV Delgado-Escueta (eds). Bethesda, NCBI, 1–11.
30. Pauli E, Hildebrandt M, Romstock J, Stefan H, Blumcke I (2006)
Deﬁcient memory acquisition in temporal lobe epilepsy is predicted by
hippocampal granule cell loss. Neurology 67:1383–1389.
31. Puvenna V, Engeler M, Banjara M, Brennan C, Schreiber P, Dadas A
et al (2016) Is phosphorylated tau unique to chronic traumatic
encephalopathy? Phosphorylated tau in epileptic brain and chronic
traumatic encephalopathy. Brain Res 1630:225–240.
32. Robertson JM (2013) Astrocyte domains and the three-dimensional
and seamless expression of consciousness and explicit memories.Med
Hypotheses 81:1017–1024.
33. Rodrigues GR, Kandratavicius L, Peixoto-Santos JE, Monteiro MR,
Gargaro AC, Geraldi Cde V et al (2015) Increased frequency of
hippocampal sclerosis ILAE type 2 in patients with mesial temporal
lobe epilepsy with normal episodic memory. Brain 138:e359.
34. Spalding KL, Bergmann O, Alkass K, Bernard S, Salehpour M,
Huttner HB et al (2013) Dynamics of hippocampal neurogenesis in
adult humans. Cell 153:1219–1227.
35. Squire LR, Wixted JT (2011) The cognitive neuroscience of human
memory since H.M. Annu Rev Neurosci 34:259–288.
36. Stefanits H, Wesseling C, Kovacs GG (2014) Loss of Calbindin
immunoreactivity in the dentate gyrus distinguishes Alzheimer’s disease
from other neurodegenerative dementias. Neurosci Lett 566:137–141.
37. Tai XY, Koepp M, Duncan JS, Fox N, Thompson P, Baxendale S et al
(2016) Hyperphosphorylated tau in patients with refractory epilepsy
correlates with cognitive decline: a study of temporal lobe resections.
Brain 139:2441–2455.
38. Takeda A, Tamano H, Ogawa T, Takada S, Nakamura M, Fujii H,
Ando M (2014) Intracellular Zn(21) signaling in the dentate gyrus is
required for object recognition memory. Hippocampus 24:1404–1412.
39. Tamano H, Koike Y, Nakada H, Shakushi Y, Takeda A (2016)
Signiﬁcance of synaptic Zn signaling in zincergic and non-zincergic
synapses in the hippocampus in cognition. J Trace Elem Med Biol 38:
93–98.
40. Thom M (2014) Review: hippocampal sclerosis in epilepsy: a
neuropathology review. Neuropathol Appl Neurobiol 40:520–543.
41. Thom M, Liagkouras I, Elliot KJ, Martinian L, Harkness W, McEvoy
A et al (2010) Reliability of patterns of hippocampal sclerosis as
predictors of postsurgical outcome. Epilepsia 51:1801–1808.
42. Thom M, Liu JY, Thompson P, Phadke R, Narkiewicz M, Martinian L
et al (2011) Neuroﬁbrillary tangle pathology and Braak staging in
chronic epilepsy in relation to traumatic brain injury and hippocampal
sclerosis: a post-mortem study. Brain 134:2969–2981.
43. Thompson PJ, Baxendale SA, McEvoy AW, Duncan JS (2015)
Cognitive outcomes of temporal lobe epilepsy surgery in older patients.
Seizure 29:41–45.
44. von Campe G, Spencer DD, de Lanerolle NC (1997) Morphology of
dentate granule cells in the human epileptogenic hippocampus.
Hippocampus 7:472–488.
45. Whitﬁeld DR, Vallortigara J, Alghamdi A, Howlett D, Hortobagyi T,
Johnson M et al (2014) Assessment of ZnT3 and PSD95 protein levels
in Lewy body dementias and Alzheimer’s disease: association with
cognitive impairment. Neurobiol Aging 35:2836–2844.
46. Witt JA, Coras R, Schramm J, Becker AJ, Elger CE, Blumcke I,
Helmstaedter C (2014) The overall pathological status of the left
hippocampus determines preoperative verbal memory performance in
left mesial temporal lobe epilepsy. Hippocampus 24:446–454.
47. Witt JA, Coras R, Schramm J, Becker AJ, Elger CE, Blumcke I,
Helmstaedter C (2015) Relevance of hippocampal integrity for
memory outcome after surgical treatment of mesial temporal lobe
epilepsy. J Neurol 262:2214–2224.
48. Witt JA, Helmstaedter C, Elger CE (2015) Is there evidence of a
subordinate role of the hippocampal CA1 ﬁeld for declarative memory
formation?. Brain 138:e343.
49. Yan XX, Cai Y, Shelton J, Deng SH, Luo XG, Oddo S et al (2012)
Chronic temporal lobe epilepsy is associated with enhanced
alzheimer-like neuropathology in 36 x Tg-AD mice. PLoS One 7:
e48782.
SUPPORTING INFORMATION
Additional Supporting Information may be found in the online
version of this article at the publisher’s web-site:
Table S1. Clinical data of temporal lobe epilepsy cases with no
hippocampal sclerosis used for comparison for MAP2 and
NeuN quantitative analysis.
Table S2. Antibodies and protocols for immunohistochemical
studies.
Table S3. Results of statistical analysis between pathology
measures and memory deﬁcits.
Characterising subtypes of hippocampal sclerosis and reorganization Prada Jardim et al
12 Brain Pathology •• (2017) ••–••
VC 2017 International Society of Neuropathology
